These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8350967)

  • 21. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
    Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
    Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Burkitt's lymphoma during pregnancy.
    Lam MS
    Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
    Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
    Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of extensive B-cell lymphoma in children: studies of the French Pediatric Oncology Society].
    Vannier JP; Patte C; Philip T; Zucker JM; Gentet JC; Lamagnière JP; Pein F; Rodary C
    Bull Cancer; 1988; 75(1):61-8. PubMed ID: 3258775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
    Todeschini G; Tecchio C; Degani D; Meneghini V; Marradi P; Balter R; Zanotti R; Ricetti M; Franchini M; Perona G
    Ann Oncol; 1997; 8 Suppl 1():77-81. PubMed ID: 9187436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burkitt's lymphoma: single-centre experience with modified BFM protocol.
    Harris E; Paneesha S; Jackson N; Jones L; Mahendra P
    Clin Lab Haematol; 2002 Apr; 24(2):111-4. PubMed ID: 11985557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
    Ziegler JL
    N Engl J Med; 1977 Jul; 297(2):75-80. PubMed ID: 865579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
    Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
    Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt's lymphoma in adults: a retrospective study of 46 cases.
    Ostronoff M; Soussain C; Zambon E; Ibrahim A; Bosq J; Bayle C; Pico JL; Gilles E; Moran A; Droz JP
    Nouv Rev Fr Hematol (1978); 1992; 34(5):389-97. PubMed ID: 1296192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transverse leukonychia and anti-leukemia chemotherapy].
    Bader-Meunier B; Garel D; Dommergues JP; Venencie PY
    Ann Pediatr (Paris); 1990 May; 37(5):337-8. PubMed ID: 2369052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Burkitt's lymphoma of the ovary.
    Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
    Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
    Baleydier F; Pondarre C; Pages MP; Mialou V; Kebaili K; Pracros JP; Bertrand Y
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):972-5. PubMed ID: 19131795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
    Di Nicola M; Carlo-Stella C; Mariotti J; Devizzi L; Massimino M; Cabras A; Magni M; Matteucci P; Guidetti A; Gandola L; Gianni AM
    Br J Haematol; 2004 Sep; 126(6):815-20. PubMed ID: 15352985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.